Cognyte Software Ltd.

CGNT

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 1,433,197Value: $13.5M

**Signal Note: Driehaus Capital Initiates CGNT Position** Driehaus Capital's $13.5M entry into Cognyte Software—a portfolio intelligence platform for investigation and security—signals conviction in the cybersecurity/data analytics space rather than biotech development. This position falls outside typical biotech fundamentals (pipeline, clinical catalysts) and likely reflects thesis-level exposure to AI-driven investigative software adoption across government and enterprise verticals.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: